Fu Weitao, Chen Lingfeng, Wang Zhe, Kang Yanting, Wu Chao, Xia Qinqin, Liu Zhiguo, Zhou Jianmin, Liang Guang, Cai Yuepiao
Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
Phys Chem Chem Phys. 2017 Feb 1;19(5):3649-3659. doi: 10.1039/c6cp07964d.
The activation and overexpression of fibroblast growth factor receptors (FGFRs) are highly correlated with a variety of cancers. Most small molecule inhibitors of FGFRs selectively target FGFR1-3, but not FGFR4. Hence, designing highly selective inhibitors towards FGFR4 remains a great challenge because FGFR4 and FGFR1 have a high sequence identity. Recently, two small molecule inhibitors of FGFRs, ponatinib and AZD4547, have attracted huge attention. Ponatinib, a type II inhibitor, has high affinity towards FGFR1/4 isoforms, but AZD4547, a type I inhibitor of FGFR1, displays much reduced inhibition toward FGFR4. In this study, conventional molecular dynamics (MD) simulations, molecular mechanics/generalized Born surface area (MM/GBSA) free energy calculations and umbrella sampling (US) simulations were carried out to reveal the principle of the binding preference of ponatinib and AZD4547 towards FGFR4/FGFR1. The results provided by MM/GBSA illustrate that ponatinib has similar binding affinities to FGFR4 and FGFR1, while AZD4547 has much stronger binding affinity to FGFR1 than to FGFR4. A comparison of the individual energy terms suggests that the selectivity of AZD4547 towards FGFR1 versus FGFR4 is primarily controlled by the variation of the van der Waals interactions. The US simulations reveal that the PMF profile of FGFR1/AZD4547 has more peaks and valleys compared with that of FGFR4/AZD4547, suggesting that the dissociation process of AZD4547 from FGFR1 are easily trapped into local minima. Moreover, it is observed that FGFR1/AZD4547 has much higher PMF depth than FGFR4/AZD4547, implying that it is more difficult for AZD4547 to escape from FGFR1 than from FGFR4. The physical principles provided by this study extend our understanding of the binding mechanisms and provide valuable guidance for the rational design of FGFR isoform selective inhibitors.
成纤维细胞生长因子受体(FGFRs)的激活和过表达与多种癌症高度相关。大多数FGFRs的小分子抑制剂选择性靶向FGFR1-3,而非FGFR4。因此,由于FGFR4与FGFR1具有高度的序列同一性,设计针对FGFR4的高选择性抑制剂仍然是一个巨大的挑战。最近,两种FGFRs的小分子抑制剂,波纳替尼和AZD4547,引起了极大关注。波纳替尼是一种II型抑制剂,对FGFR1/4亚型具有高亲和力,但FGFR1的I型抑制剂AZD4547对FGFR4的抑制作用则大大降低。在本研究中,进行了传统分子动力学(MD)模拟、分子力学/广义玻恩表面积(MM/GBSA)自由能计算和伞形采样(US)模拟,以揭示波纳替尼和AZD4547对FGFR4/FGFR1结合偏好的原理。MM/GBSA提供的结果表明,波纳替尼对FGFR4和FGFR1具有相似的结合亲和力,而AZD4547对FGFR1的结合亲和力比对FGFR4强得多。对各个能量项的比较表明,AZD4547对FGFR1与FGFR4的选择性主要由范德华相互作用的变化控制。US模拟表明,与FGFR4/AZD4547相比,FGFR1/AZD4547的PMF曲线有更多的峰谷,这表明AZD4547从FGFR1的解离过程很容易陷入局部最小值。此外,观察到FGFR1/AZD4547的PMF深度比FGFR4/AZD4547高得多,这意味着AZD4547从FGFR1逃逸比从FGFR4逃逸更困难。本研究提供的物理原理扩展了我们对结合机制的理解,并为FGFR亚型选择性抑制剂的合理设计提供了有价值的指导。